BNTC Benitec Corp Year-over-year net earnings per share growth for the last 12 months
Should investors expect growth for Benitec Biopharma Inc. (BNTC) given the upcoming data on muscular dystrophy therapy? The answer lies in the proprietary defective gene suppression system, which creates a unique intellectual property portfolio. The quarter-over-quarter EPS trend illustrates the impact of cost inflation, while the -21.00 value indicates the status of current margins. Business funding relies on investments and specialized grants.
Analytical breakdowns for Benitec Biopharma Inc.
- share price and expert price forecast:
- market capitalization data:
- book capitalization indicators:
- business debt structure and liquidity details:
Debt to Equity Benitec Biopharma Inc.|BNTC - Long-Term Liabilities to Capital|Short-Term Debt to Equity Benitec Biopharma Inc.|BNTC - Company Aggregate Indebtedness|Debts to Book Capitalization Benitec Biopharma Inc.|BNTC - Company Long-Term Loans and Borrowings|Company Short-Term Debts Benitec Biopharma|Quick Liquidity benitec.com
- earnings and valuation multiples indicators:
BNTC - Final Profit|Expected Profit Benitec Biopharma Inc.|BNTC - Price to Earnings Ratio|Forward P/E Multiple Benitec Corp|BNTC - PEG Multiple|Enterprise Value to EBITDA Ratio Benitec Biopharma Inc.|BNTC - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Benitec Biopharma|BNTC - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months benitec.com|BNTC - Earnings per share growth this year|Earnings growth forecast for next year Benitec Biopharma Inc.
- sales volume and revenue information:
General company analysis:Benitec - BNTC
Quarterly EPS growth determines the rate of change in net profit per share, serving as a fundamental criterion for business stability. A mathematical comparison of current periods against historical data filters out market noise and reveals the actual efficiency of capital management. By analyzing the shift in quarterly EPS levels, an investor assesses the issuer's ability to generate value. For Benitec Biopharma Inc. (BNTC), this trend confirms financial stability while outsourcing the production of viral vectors. Long-term vendor contracts minimize operational shocks, maintaining earnings predictability.
Who Benitec Biopharma Inc. competes with
TEM: Quarterly EPS earnings growth|Qiagen Corp - Year-over-year earnings per one share growth for the last 12 months|IONS (Ionis Pharmaceuticals) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months RGEN (Repligen)|Quarterly EPS earnings growth RNA|CRSP (CRISPR Therapeutics) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth WGS (GeneDx Holdings Corp.)|RARE: Year-over-year earnings per share growth for the last 12 months|BEAM - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months sarepta.com|TWST: Quarterly EPS earnings growth|TXG - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Intellia|Earnings per share growth in annualized terms for the last twelve months Stoke Therapeutics STOK|Quarterly EPS earnings growth BLFS|Wave Life Sciences - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth MAZE (Maze Therapeutics, Inc.)|Quarterly EPS earnings growth Sionna Pharma SION|Prime Medicine Bio - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months TSHA (Taysha)|QURE: Quarterly EPS earnings growth|MGTX - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months RGNX|SLDB: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months ocugen.com (OCGN)|Year-over-year net earnings per share change for the last twelve months PacBio Corp|Quarterly EPS earnings growth DSGN (Design Therapeutics, Inc.)|Quarterly EPS earnings growth rocketpharma.com RCKT|4DMT - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Lexeo Therapeutics, Inc.|Korro Bio (KRRO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months EDIT|SLN (Silence Therapeutics plc) - Quarterly EPS earnings growth|proqr.com (PRQR) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months CDXS (Codexis Bio)|SGMO - Earnings per share growth in annualized terms for the last twelve months|Nautilus Biotechnology, Inc. - Year-over-year net earnings per share growth for the last 12 months|Net earnings per share growth for the trailing year Metagenomi, Inc|Precision BioSciences - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year generationbio.com (GBIO)|Boundless Bio Inc (BOLD) - Year-over-year earnings per share growth for the last twelve months|Exicure Inc. - Year-over-year earnings per one share growth for the last 12 months|IMNN (imunon.com) - Quarterly EPS earnings growth|Phio Pharmaceuticals - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Mustang Bio Corp (MBIO)|Quarterly EPS earnings growth TransCode (RNAZ)|Quarterly EPS earnings growth BNGO (bionanogenomics.com)|APDN (Applied DNA Sciences Inc) - Year-over-year net earnings per share trend for the last twelve months|BLUE - Year-over-year earnings per share growth for the last twelve months|ImmunoPrecise Antibodies Ltd. (IPA) - Year-over-year net earnings per share growth for the last 12 months|OMGA (Omega) - Year-over-year net earnings per share growth for the last 12 months|singulargenomics.com (OMIC) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months RGLS|Syros (SYRS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months telesisbio.com (TBIO)|TCON - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth UBX (Unity Biotechnology Inc.)
